After pricing 625,000 ADSs at $4.00 each, OKYO Pharma Limited (Nasdaq : OKYO), today’s IPO opened at $4.50 per ADS. This represents 40.625,000 ordinary shares with no par value and represents 4.00 per ADS.

ThinkEquity LLC was solely responsible for bookrunning the IPO.

OKYO Pharma is an innovative life science company that focuses on the development and discovery of new molecules for treating inflammatory dry eyes diseases and ocular discomfort.